- Home
- CRT vs EDAP Comparison
CRT vs EDAP Comparison
Compare CRT & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRT
- EDAP
- Stock Information
- Founded
- CRT 1991
- EDAP 1979
- Country
- CRT United States
- EDAP France
- Employees
- CRT N/A
- EDAP N/A
- Industry
- CRT Oil & Gas Production
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CRT Energy
- EDAP Health Care
- Exchange
- CRT Nasdaq
- EDAP Nasdaq
- Market Cap
- CRT 65.1M
- EDAP 53.8M
- IPO Year
- CRT 1992
- EDAP 1997
- Fundamental
- Price
- CRT $9.79
- EDAP $1.70
- Analyst Decision
- CRT
- EDAP Buy
- Analyst Count
- CRT 0
- EDAP 3
- Target Price
- CRT N/A
- EDAP $8.50
- AVG Volume (30 Days)
- CRT 26.8K
- EDAP 27.6K
- Earning Date
- CRT 01-01-0001
- EDAP 05-15-2025
- Dividend Yield
- CRT 9.32%
- EDAP N/A
- EPS Growth
- CRT N/A
- EDAP N/A
- EPS
- CRT 0.99
- EDAP N/A
- Revenue
- CRT $6,834,116.00
- EDAP $67,840,467.00
- Revenue This Year
- CRT N/A
- EDAP N/A
- Revenue Next Year
- CRT N/A
- EDAP N/A
- P/E Ratio
- CRT $9.85
- EDAP N/A
- Revenue Growth
- CRT N/A
- EDAP 3.69
- 52 Week Low
- CRT $8.88
- EDAP $1.26
- 52 Week High
- CRT $13.31
- EDAP $5.46
- Technical
- Relative Strength Index (RSI)
- CRT 44.17
- EDAP 40.81
- Support Level
- CRT $9.95
- EDAP $1.63
- Resistance Level
- CRT $10.38
- EDAP $1.79
- Average True Range (ATR)
- CRT 0.25
- EDAP 0.09
- MACD
- CRT 0.03
- EDAP -0.00
- Stochastic Oscillator
- CRT 45.38
- EDAP 25.93
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.